• Something wrong with this record ?

CHD8-related disorders redefined: an expanding spectrum of dystonic phenotypes

U. Sorrentino, S. Boesch, D. Doummar, C. Ravelli, T. Serranova, E. Indelicato, J. Winkelmann, L. Burglen, R. Jech, M. Zech

. 2024 ; 271 (5) : 2859-2865. [pub] 20240305

Language English Country Germany

Document type Journal Article, Case Reports

E-resources Online Full text

NLK ProQuest Central from 1997-04-01 to 1 year ago
Medline Complete (EBSCOhost) from 2000-01-01 to 1 year ago
Health & Medicine (ProQuest) from 1997-04-01 to 1 year ago

BACKGROUND: Heterozygous loss-of-function variants in CHD8 have been associated with a syndromic neurodevelopmental-disease spectrum, collectively referred to as CHD8-related neurodevelopmental disorders. Several different clinical manifestations, affecting neurodevelopmental and systemic domains, have been described, presenting with highly variable expressivity. Some expressions are well established and comprise autism spectrum disorders, psychomotor delay with cognitive impairment, postnatal overgrowth with macrocephaly, structural brain abnormalities, gastrointestinal disturbances, and behavioral and sleep-pattern problems. However, the complete phenotypic spectrum of CHD8-related disorders is still undefined. In 2021, our group described two singular female patients with CHD8-related neurodevelopmental disorder and striking dystonic manifestations, prompting the suggestion that dystonia should be considered a possible component of this condition. CASE SERIES PRESENTATION: We describe three additional unrelated female individuals, each carrying a different CHD8 frameshift variant and whose clinical presentations were primarily characterized by young-onset dystonia. Their dystonic manifestations were remarkably heterogeneous and ranged from focal, exercise-dependent, apparently isolated forms to generalized permanent phenotypes accompanied by spasticity and tremor. Neurocognitive impairment and autistic behaviors, typical of CHD8-related disorders, were virtually absent or at the mild end of the spectrum. CONCLUSIONS: This work validates our previous observation that dystonia is part of the phenotypic spectrum of CHD8-related neurodevelopmental disorders with potential female preponderance, raising new challenges and opportunities in the diagnosis and management of this condition. It also highlights the importance of in-depth neurologic phenotyping of patients carrying variants associated with neurodevelopmental disorders, as the connection between neurodevelopmental and movement disorders is proving closer than previously appreciated.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24014133
003      
CZ-PrNML
005      
20240905133450.0
007      
ta
008      
240725s2024 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00415-024-12271-x $2 doi
035    __
$a (PubMed)38441608
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Sorrentino, Ugo $u Institute of Human Genetics, School of Medicine, Technical University of Munich, Munich, Germany. ugo.sorrentino@unipd.it $u Institute of Neurogenomics, Helmholtz Munich, Neuherberg, Germany. ugo.sorrentino@unipd.it $u Clinical Genetics Unit, Department of Women's and Children's Health, University of Padova, Padua, Italy. ugo.sorrentino@unipd.it $1 https://orcid.org/0000000181396198
245    10
$a CHD8-related disorders redefined: an expanding spectrum of dystonic phenotypes / $c U. Sorrentino, S. Boesch, D. Doummar, C. Ravelli, T. Serranova, E. Indelicato, J. Winkelmann, L. Burglen, R. Jech, M. Zech
520    9_
$a BACKGROUND: Heterozygous loss-of-function variants in CHD8 have been associated with a syndromic neurodevelopmental-disease spectrum, collectively referred to as CHD8-related neurodevelopmental disorders. Several different clinical manifestations, affecting neurodevelopmental and systemic domains, have been described, presenting with highly variable expressivity. Some expressions are well established and comprise autism spectrum disorders, psychomotor delay with cognitive impairment, postnatal overgrowth with macrocephaly, structural brain abnormalities, gastrointestinal disturbances, and behavioral and sleep-pattern problems. However, the complete phenotypic spectrum of CHD8-related disorders is still undefined. In 2021, our group described two singular female patients with CHD8-related neurodevelopmental disorder and striking dystonic manifestations, prompting the suggestion that dystonia should be considered a possible component of this condition. CASE SERIES PRESENTATION: We describe three additional unrelated female individuals, each carrying a different CHD8 frameshift variant and whose clinical presentations were primarily characterized by young-onset dystonia. Their dystonic manifestations were remarkably heterogeneous and ranged from focal, exercise-dependent, apparently isolated forms to generalized permanent phenotypes accompanied by spasticity and tremor. Neurocognitive impairment and autistic behaviors, typical of CHD8-related disorders, were virtually absent or at the mild end of the spectrum. CONCLUSIONS: This work validates our previous observation that dystonia is part of the phenotypic spectrum of CHD8-related neurodevelopmental disorders with potential female preponderance, raising new challenges and opportunities in the diagnosis and management of this condition. It also highlights the importance of in-depth neurologic phenotyping of patients carrying variants associated with neurodevelopmental disorders, as the connection between neurodevelopmental and movement disorders is proving closer than previously appreciated.
650    _2
$a lidé $7 D006801
650    _2
$a ženské pohlaví $7 D005260
650    12
$a fenotyp $7 D010641
650    12
$a DNA vazebné proteiny $x genetika $7 D004268
650    _2
$a dystonie $x genetika $x etiologie $x patofyziologie $x diagnóza $7 D004421
650    _2
$a transkripční faktory $x genetika $7 D014157
650    _2
$a dítě $7 D002648
650    _2
$a mladiství $7 D000293
650    _2
$a neurovývojové poruchy $x genetika $x diagnóza $7 D065886
650    _2
$a dospělí $7 D000328
650    _2
$a dystonické poruchy $x genetika $x diagnóza $x patofyziologie $x komplikace $7 D020821
650    _2
$a posunová mutace $7 D016368
650    _2
$a mladý dospělý $7 D055815
650    _2
$a předškolní dítě $7 D002675
655    _2
$a časopisecké články $7 D016428
655    _2
$a kazuistiky $7 D002363
700    1_
$a Boesch, Sylvia $u Center for Rare Movement Disorders Innsbruck, Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria
700    1_
$a Doummar, Diane $u Sorbonne Université, Service de Neuropédiatrie-Pathologie du Développement, Centre de Référence Neurogénétique, Hôpital Trousseau AP-HP.SU, HU I2D2, Paris, France
700    1_
$a Ravelli, Claudia $u Sorbonne Université, Service de Neuropédiatrie-Pathologie du Développement, Centre de Référence Neurogénétique, Hôpital Trousseau AP-HP.SU, HU I2D2, Paris, France
700    1_
$a Serranova, Tereza $u Department of Neurology and Centre of Clinical Neuroscience, General University Hospital and First Faculty of Medicine, Charles University, Kateřinská 30, 12 800, Prague, Czech Republic
700    1_
$a Indelicato, Elisabetta $u Center for Rare Movement Disorders Innsbruck, Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria
700    1_
$a Winkelmann, Juliane $u Institute of Human Genetics, School of Medicine, Technical University of Munich, Munich, Germany $u Institute of Neurogenomics, Helmholtz Munich, Neuherberg, Germany $u DZPG, Deutsches Zentrum Für Psychische Gesundheit, Munich, Germany $u Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
700    1_
$a Burglen, Lydie $u Cerebellar Malformations and Congenital Diseases Reference Center and Neurogenetics Lab, Department of Genetics, Armand Trousseau Hospital, AP-HP. Sorbonne Université, Paris, France $u Developmental Brain Disorders Laboratory, Imagine Institute, INSERM UMR 1163, Paris, France
700    1_
$a Jech, Robert $u Department of Neurology and Centre of Clinical Neuroscience, General University Hospital and First Faculty of Medicine, Charles University, Kateřinská 30, 12 800, Prague, Czech Republic
700    1_
$a Zech, Michael $u Institute of Human Genetics, School of Medicine, Technical University of Munich, Munich, Germany $u Institute of Neurogenomics, Helmholtz Munich, Neuherberg, Germany $u Institute for Advanced Study, Technical University of Munich, Garching, Germany
773    0_
$w MED00002835 $t Journal of neurology $x 1432-1459 $g Roč. 271, č. 5 (2024), s. 2859-2865
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38441608 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905133444 $b ABA008
999    __
$a ok $b bmc $g 2143737 $s 1225999
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 271 $c 5 $d 2859-2865 $e 20240305 $i 1432-1459 $m Journal of neurology $n J Neurol $x MED00002835
LZP    __
$a Pubmed-20240725

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...